1Suyash college of pharmacy warud BK, Jalna, Maharashtra
2Laddhad College Of Pharmacy Yelgaon, Buldhana, Maharashtra
Tablets are the most commonly prescribed dosage form as offer a convenient form of drug administration provides dosage uniformity from tablet to tablet. Medicines are not just a science but an art, involving understanding the processes of life. Pharmaceutical oral solid dosage forms have been widely used for decades due to their convenience and suitability for systemic effects. Tablets, made from powders, granules, pellets, or film-coated units, are the most popular dosage form, accounting for 70% of ethical pharmaceutical preparations. They can be prepared using compression or moulding methods, and can be further classified as compressible tablets, chewable tablets, or tablet triturates. Tablets can be prepared from powders, granules, pellets, or film-coated multiple units.
The oral route is the most preferred method of drug administration due to its ease of administration, patient acceptance, accurate dosing, and cost-effectiveness. Solid medicaments can be administered orally in various forms, including tablets, powders, pills, cachets, capsules, and tablets. Tablets are the most widely used dosage form due to their simplicity, lower production costs, and aesthetic quality. They can be manufactured through dry granulation, wet granulation, or direct compression, with or without excipients, and are designed to produce desired pharmacological responses. The oral route is popular for systemic effects due to its ease of ingestion, pain avoidance, versatility, and patient compliance. Solid oral delivery systems, particularly tablets, are the preferred choice due to their cost-effectiveness and lack of special treatment. The ideal dosage regimen for drug therapy is one that immediately attains the desired therapeutic concentration of the drug in plasma or the site of action and maintains it constant throughout treatment. Oral drug delivery is the most widely used route among nasal, ophthalmic, rectal, and parental routes for systemic drug delivery. It is considered the most natural, uncomplicated, convenient, and safe due to its ease of administration, patient acceptance, and cost-effective manufacturing. Pharmaceutical products designed for oral delivery are mainly immediate release type or conventional drug delivery systems, designed for rapid absorption.
Definition
According to the Indian Pharmacopoeia (IP); Pharmaceutical tablets are solid, flat orbiconvex dishes, unit dosage form, prepared by compressing a drug or a mixture of drugs, with or without diluents. According to the United States of Pharmacopoeia (USP); Tablet is defined as a compressed solid dosage form containing medicaments with or without excipients. According to the Indian Pharmacopoeia Pharmaceutical tablets are solid, flat or biconvex dishes, dosage form, prepared by compressing a drugs or a mixture of drugs, with or without diluents. It is the most popular dosage form and 70% of the total medicines are dispensed in the form of Tablet.
Advantages
Disadvantages
General properties of Tablets:
Classification of tablets
1. USE Wise:
A. Oral tablets for ingestion
Compression Coated Tablets – a) Sugar coated b) Film coated tablets, c) Gelatin coated tablets, d) Enteric coated tablets, e) Layered tablets
B. Tablets used in the oral cavity
C. Tablets administered by other routes
D. Tablets used to prepare solution
Hypodermic tablets
Dispensing /soluble tablet
2. Structure wise
3. Action wise
1. Modified release tablet
Based on the route of administration or the function, the tablets are classified as follows.
1. Tablets ingested orally.
2. Tablets used in the oral cavity.
3. Tablets administered by other routes.
Formulation of tablets
Many excipients for pharmaceutical use are available in several grades. Both classes are often classified by physical and chemical properties. explanation for the grades is to modify the excipient performance characteristics. Excipients are chosen in a tablet formulation to perform variety of functions like for providing essential manufacturing technology functions (binders, glidant, lubricants may be added), for patient acceptance (flavors, colorants may be added), for providing aid in product identification (colorants may be added), for Optimizing or modifying drug release (disintegrant, hydrophilic polymers, wetting agents, biodegradable polymers may be added), for enhancing stability (antioxidant UV absorbers may be added).
Diluents:
Diluents are fillers used to make required bulk of the tablet when the drug dosage itself is inadequate to produce the bulk. Also used to improve cohesion, to permit use of direct compression.
Glidants
Glidants are intended to promote flow of granules or powder material by reducing the friction between the particles.
Tablet formulation uses wetting agents like Sodium Lauryl Sulphate (SLS) to improve disintegration aid in drug dissolution. SLS accelerates dissolution by destroying the path through which drugs must pass, minimizing the path length for the drug to travel. This helps in accelerating drug dissolution through biological membranes. Sodium di-isobutyl is a common wetting agent in tablet formulation.
Dissolution retardants are introduced into tablet formulation when the controlled release of is necessarye.g. stearic acid and their esters etc
These are the agents that alter the molecular forces between ingredients to enhance dissolution of a solutein the solvent e.g. fructose, povidone, surfactants etc.
The agents that can retain large quantities of liquids are known as adsorbents. Therefore liquids like Vitamin Ecan be incorporated into tablets by the addition of adsorbents. e.g. Anhydrous calcium phosphate, starch, magnesium carbonate, bentonite, kaolin, magnesium silicate magnesium oxide, and silicon dioxide.
Buffers are added to maintain a required pH in the formulation. Since a change in pH may cause significant alteration in the stability e.g. Sodium bicarbonate, calcium carbonate, and citrate etc.
Antioxidants are added in a tablet formulation to prevent oxidation. Antioxidants oxidation instead of drugs or block the reaction to oxidation, or act as synergists with other antioxidants. Chelators can act as antioxidants, too. e.g. ascorbic acid and their esters, alpha-tocopherol, ethylene di-amine tetra-acetic acid, sodium metabisulfite, sodium bisulfite, butylated hydroxy toluene (BHT), butylated hydroxy anisole (BHA), citric acid and tartaric acid.
Chelating agents tend to form complexes with trace amounts of heavy metal ions inactivate their catalytic activity in drug oxidation e.g. ethylene-di-amine tetra acetic acid and its salts, di hydroxy ethyl glycine, citric acid and tartaric acid.
Preservatives may be a part of tablet formulation. It prevents the growth of microorganisms in tablet formulatione.g. parabens like methyl, propyl, benzyl, butyl p-hydroxybenzoate are used as preservatives.
Colorants are used in tablets to identify similar products within a product line, avoid mix-ups, and enhance brand image. They do not contribute to therapeutic action or drug stability, but they help overcome color change on aging, disguise off-color drugs, and enhance the aesthetic appearance of products, ultimately leading to better patient acceptance.Some commonly used pharmaceutical colorants shown in No.5.
Flavors are commonly used to improve the taste of chewable and mouth dissolved tablets Flavors may be incorporated as either solids (spray-dried flavors) or oils or aqueous (water-soluble flavors)
Sweeteners are added primarily to chewable tablets. Table No.6 shows different types of pharmaceutical sweeteners).
preparation:
Tablets are prepared by three methods
Direct compression involves direct compressing the powdered material into tablets. Direct compression is adopted, if drug constitutes major portion of tablet [86-90] total weight (Figure 1). Tablets containing 25% or less of drug substances can be formulated, with a suitable diluent which acts as a carrier or vehicle for the drug. Tablets prepared by above method are subjected to compression machine which may be single station or multiple stations
The most common method for tablet production involves weighing ingredients, mixing, granulation, screening, drying, lubrication, and compression. The main active ingredient, diluent, and disintegrant are blended, then passed through a sieve. The binding agent is added to the mixture, stirring to avoid over-wetting. Tray drying is the most common method, but may be replaced by fluid-bed dryers as a novel approach. After drying, the granules pass through a screen, usually 60-100 mesh nylon cloth. Lubricant is added as a fine powder to fill the die cavity. This method ensures proper granulation and prevents over-wetting during lubrication and compression.
This method is used for tablet preparation, in case tablet ingredients are highly sensitive to moisture, or unable to with stand elevated temperatures during drying, slugging may be used to form the granules. Dry granulation or double compression, usually eliminates various steps, which involves slugging of the powder mass.The active ingredient, diluent and lubricant are blended together, to form the slug. Thus, the compressed slug is passed through the mesh or through the mill, and the remaining lubricant is added to the granulation, blended properly and compressed to form the tablets
Evaluation of Tablet:
The general appearance of a tablet, its identity and general elegance is essential for consumer acceptance, for control of lot?to?lot uniformity and tablet?to?tablet uniformity. The control of general appearance involves the measurement of size, shape, color, presence or absence of odor, taste etc.
It can be dimensionally described & controlled. The thickness of a tablet is only variables. Tablet thickness can be measured by micrometer or by other device. Tablet thickness should be controlled within a ± 5% variation of standard value.
These marking utilize some form of embossing, engraving or printing. These markings include company name or symbol, product code, product name etc.
Color distribution must be uniform with no mottling. For visual color comparison compare the color of sample against standard color.
Tablet requires a certain amount of strength or hardness and resistance to friability to withstand mechanical shakes of handling in manufacture, packaging and shipping. Hardness generally measures the tablet crushing strength
Fig 1 . Pfizer type hardness tester
Fig. 2. Monsanto hardness tester
Friability of a tablet can determine in laboratory by Roche friabilator. This consist of a plastic chamber that revolves at 25 rpm, dropping the tablets through a Distance of six inches in the friabilator, which is then operate for 100 revolutions. The tablets are reweighed. Compress tablet that lose less than 0.5 to 1.0 % of the Tablet weigh are consider acceptable.
Fig. 3. Digital Friability Test Apparatus
7. Drug Content and Release:
Take 20 tablet and weighed individually. Calculate average weight and compare the individual tablet weight to the average. The tablet pass the U.S.P. test if no more that 2 tablets are outside the percentage limit and if no tablet differs by more than 2 times the percentage limit.
Randomly select 30 tablets. 10 of these assayed individually. The Tablet pass the test if 9 of the 10 tablets must contain not less than 85% and not more than 115% of the labeled drug content and the 10th tablet may not contain less than 75% and more than 125% of the labeled content. If these conditions are not met, remaining 20 tablet assayed individually and none may fall outside of the 85 to 115% range.
The U.S.P. device to test disintegration uses 6 glass tubes that are 3” long; open at the top and 10 mesh screen at the bottom end. To test for disintegration time, one tablet is placed in each tube and the basket rack is positioned in a 1?L beaker of water, simulated gastric fluid or simulated intestinal fluid at 37 ± 2 0 C such that the tablet remain 2.5 cm below the surface of liquid on their upward movement and not closer than 2.5 cm from the bottom of the beaker in their downward movement. Move the basket containing the tablets up and down through a distance of 5?6 cm at a frequency of 28 to 32 cycles per minute. Floating of the tablets can be prevented by placing perforated plastic discs on each tablet. According to the test the tablet must disintegrate and all particles must pass through the 10 mesh screen in the time specified. If any residue remains, it must have a soft mass. Disintegration time: Uncoated tablet: 5?30 minutes Coated tablet: 1?2 hours
Fig. 4. Disintegration test apparatus
3.Dissolution Test (U.S.P.):
Two set of apparatus:
Apparatus?1:
A single tablet is placed in a small wire mesh basket attached to the bottom of the shaft connected to a variable speed motor. The basket is immersed in a dissolution medium (as specified in monograph) contained in a 100 ml flask. The flask is cylindrical with a hemispherical bottom. The flask is maintained at 37±0.50C by a constant temperature bath. The motor is adjusted to turn at the specified speed and sample of the fluid are withdrawn at intervals to determine the amount of drug in solutions.
Apparatus?2:
It is same as apparatus?1, except the basket is replaced by a paddle. The dosage form is allowed to sink to the bottom of the flask before stirring. For dissolution test U.S.P. specifies the dissolution test medium and volume, type of apparatus to be used, rpm of the shaft, time limit of the test and assay procedure for. The test tolerance is expressed as a % of the labeled amount of drug dissolved in the time limit
Fig. 5. Dissolution Test Apparatus
CONCLUSION:
Tablet manufacturing and evaluation have become crucial in pharmaceutical research, with tablets demonstrating uniqueness and adaptability. Over the past few decades, advancements in manufacturing and evaluation techniques have been economical and time-saving. The availability of various manufacturing and evaluation parameters has enhanced researchers' scope, allowing tablets to perfectly fit into the ever-changing drug world.
REFERENCES
Ganesh U. Chavan, Payal V. Suradkar, Trupti D. Hudekar, A Comprehensive Review On: Tablet, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 10, 794-805. https://doi.org/10.5281/zenodo.13963865